Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Furst

Showing results (231-240 of 755) with videos related to

Pageof 76
Sort By:
The Journal of Rheumatology|August 1, 1987
Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blockerP A Rupp, S Mellinger, J Kohler, et al.
Muscle & Nerve|April 14, 2012
Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care planDaniel E Furst, Anthony A Amato, Şerban R Iorga, et al.
Journal of Scleroderma and Related Disorders|April 7, 2022
Responsiveness of the University of California Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal tract 2.0 (UCLA-SCTC-GIT 2.0)to change in scleroderma patientsYossra Atef Suliman, Suzanne Kafaja, Mohamed Alemam, et al.
The Journal of Rheumatology|June 1, 1984
Case control study of antibodies to ENA in progressive systemic sclerosis patientsD E Furst, M Obrodovic, E V Barnett, et al.
Annals of the Rheumatic Diseases|December 1, 1984
Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease durationD E Furst, P J Clements, M Saab, et al.
Clinical Immunology (Orlando, Fla.)|July 18, 2006
Normal interleukin-7 (IL7) levels and normal IL7 response to CD4 T lymphopenia in patients with multiple sclerosis and systemic sclerosisJan Storek, Richard A Nash, Peter A McSweeney, et al.
Annals of the Rheumatic Diseases|January 26, 2013
Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysisJérôme Avouac, Dörte Huscher, Daniel E Furst, et al.
Annals of the Rheumatic Diseases|January 20, 2007
The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosisLászló Czirják, Zoltán Nagy, Martin Aringer, et al.
Rheumatology and Therapy|November 23, 2019
Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial DataPaul Emery, Daniel E Furst, Petra Kirchner, et al.
Arthritis and Rheumatism|March 1, 1976
Letter: Effects of salicylate on liver enzymes in normal young adultsD E Furst, N C Kar, E S Sarkissian, et al.
Pageof 76

Showing results (231-240 of 755) with videos related to

Sort By:
Pageof 76
The Journal of Rheumatology|August 1, 1987
Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blockerP A Rupp, S Mellinger, J Kohler, et al.
Muscle & Nerve|April 14, 2012
Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care planDaniel E Furst, Anthony A Amato, Şerban R Iorga, et al.
Journal of Scleroderma and Related Disorders|April 7, 2022
Responsiveness of the University of California Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal tract 2.0 (UCLA-SCTC-GIT 2.0)to change in scleroderma patientsYossra Atef Suliman, Suzanne Kafaja, Mohamed Alemam, et al.
The Journal of Rheumatology|June 1, 1984
Case control study of antibodies to ENA in progressive systemic sclerosis patientsD E Furst, M Obrodovic, E V Barnett, et al.
Annals of the Rheumatic Diseases|December 1, 1984
Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease durationD E Furst, P J Clements, M Saab, et al.
Clinical Immunology (Orlando, Fla.)|July 18, 2006
Normal interleukin-7 (IL7) levels and normal IL7 response to CD4 T lymphopenia in patients with multiple sclerosis and systemic sclerosisJan Storek, Richard A Nash, Peter A McSweeney, et al.
Annals of the Rheumatic Diseases|January 26, 2013
Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysisJérôme Avouac, Dörte Huscher, Daniel E Furst, et al.
Annals of the Rheumatic Diseases|January 20, 2007
The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosisLászló Czirják, Zoltán Nagy, Martin Aringer, et al.
Rheumatology and Therapy|November 23, 2019
Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial DataPaul Emery, Daniel E Furst, Petra Kirchner, et al.
Arthritis and Rheumatism|March 1, 1976
Letter: Effects of salicylate on liver enzymes in normal young adultsD E Furst, N C Kar, E S Sarkissian, et al.
Pageof 76